QuidelOrtho Receives FDA Clearance for QuickVue COVID-19 Test

Tuesday, 2 April 2024, 13:17
The FDA has granted QuidelOrtho 510(k) clearance for their QuickVue COVID-19 test, marking a significant milestone in the fight against the pandemic. The approval paves the way for expanded testing capabilities and increased accessibility to reliable diagnostic tools. QuidelOrtho's QuickVue test demonstrates the commitment to innovation and public health safety amidst the ongoing health crisis.
LivaRava Finance Meta Image
QuidelOrtho Receives FDA Clearance for QuickVue COVID-19 Test

QuidelOrtho Secures FDA Approval for QuickVue COVID-19 Test

QuidelOrtho has received FDA 510(k) clearance for its QuickVue COVID-19 test, a pivotal development in the company's ongoing efforts to combat the pandemic. This approval underscores the test's reliability and accuracy in diagnosing COVID-19 infections, providing healthcare professionals and the public with a valuable tool in the battle against the virus.

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe